Neuropathic Pain Market is Expected to Surpass US$ 5.4 Bn by 2016 | Página 3
R e s e a r c h
M a r k e t
On the basis of indication, the market has been segmented into Diabetic Neuropathy,
Chemotherapy Induced Peripheral Neuropathy, and Others. The highest market share is held by
the Diabetic Neuropathy segment, followed by the Chemotherapy Induced Peripheral
Neuropathy segment. The Diabetic Neuropathy segment is estimated to account for the highest
value share of 46.7% of the global neuropathic pain market by 2016 end. The Chemotherapy
Induced Peripheral Neuropathy segment is estimated to account for 42.4% revenue share in the
global neuropathic pain market by 2016 end.
Download Report Table of Content, Figures, and Tables @
http://www.persistencemarketresearch.com/market-research/neuropathic-painmarket/toc
On the basis of region, the market has been segmented into North America, Latin America,
Europe, Asia Pacific, and Middle East & Africa. This report assesses trends driving each market
segment and offers analysis and insights into the potential of neuropathic pain in specific
regions. North America is estimated to dominate the global neuropathic pain market with
maximum value share of the overall market by the end of 2016. The North America neuropathic
pain market is estimated to increase at a CAGR of 5.8% through 2024. Emergence of several
regional market players, a robust distribution network, and well-developed healthcare
infrastructure support in North America are some of the key factors driving revenue growth of the
neuropathic pain market in North America.
P e r s i s t e n c e
The global neuropathic pain market report profiles some of the top players operating in the
global neuropathic pain market such as Baxter Healthcare Corporation, Depomed, Inc.,
GlaxoSmithKline PLC, Biogen Idec, Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc.,
Eli Lily and Company, and Bristol Myers Squibb. These companies are primarily focusing on
producing improved drugs for the treatment of neuropathic pain to gain maximum share in the
global neuropathic pain market.
Browse Complete Report @ http://www.persistencemarketresearch.com/marketresearch/neuropathic-pain-market.asp
Global Neuropathic Pain Market 2016-2024